Search Results

Your search for SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD matches 2 pages

Showing 1 - 2

By SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD / February 10, 2020

Selected ASH Abstracts on Myelodysplastic Syndromes

To complement The ASCO Post’s continued comprehensive coverage of the 2019 American Society of Hematology (ASH) Annual Meeting & Exposition, here are several abstracts selected from the meeting proceedings focusing on novel therapies for myelodysplastic syndromes (MDS), including the...

myelodysplastic syndromes

By Syed Ali Abutalib, MD, and Alan F. List, MD / February 10, 2019 / 2018 ASH Annual Meeting & Exposition

Novel Treatments of Myelodysplastic Syndromes

AS PART of The ASCO Post’s continued coverage of the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition, here is an update on seven different studies on new therapeutics in myelodysplastic syndromes (MDS). Among the treatments highlighted here are the erythroid maturation...

Nov

Today In Oncology

Search Results

Your search for SYED ALI ABUTALIB, MD, and ALAN F. LIST, MD matches 2 pages

Selected ASH Abstracts on Myelodysplastic Syndromes

Novel Treatments of Myelodysplastic Syndromes

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma

Neuro-Oncology Guidelines Reveal How AI Could Improve Brain Cancer Diagnosis Monitoring and Treatment

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer